Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration.

Adamis, Anthony P; de Juan, Eugene

Adamis, Anthony P; de Juan, Eugene.

Affiliation

Adamis AP; Genentech, Inc., South San Francisco.
de Juan E; University of California, San Francisco, San Francisco.

Curr Opin Ophthalmol ; 33(3): 131-136, 2022 May 01.

Article in En | MEDLINE | ID: mdl-35266895

Subject(s)

Diabetic Retinopathy; Macular Degeneration; Macular Edema; Wet Macular Degeneration; Angiogenesis Inhibitors/therapeutic use; Antibodies, Monoclonal/therapeutic use; Diabetic Retinopathy/drug therapy; Humans; Intravitreal Injections; Macular Degeneration/drug therapy; Macular Edema/drug therapy; Ranibizumab/therapeutic use; Treatment Outcome; Wet Macular Degeneration/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Macular Edema / Diabetic Retinopathy / Wet Macular Degeneration / Macular Degeneration Limits: Humans Language: En Journal: Curr Opin Ophthalmol Journal subject: OFTALMOLOGIA Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google